-
1
-
-
33845971890
-
The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes
-
Lorenzo, C., Williams, K., Hunt, K. J., & Haffner, S. M. (2007). The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care, 30 (1), 8-13.
-
(2007)
Diabetes Care
, vol.30
, Issue.1
, pp. 8-13
-
-
Lorenzo, C.1
Williams, K.2
Hunt, K.J.3
Haffner, S.M.4
-
2
-
-
33847187395
-
Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus
-
Rader, D. J. (2007). Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. The American Journal of Medicine, 120(3 Suppl 1), S12-S18.
-
(2007)
The American Journal of Medicine
, vol.120
, Issue.3 SUPPL. 1
-
-
Rader, D.J.1
-
3
-
-
1542344902
-
Type 2 diabetes mellitus: A disease of the innate immune system? An update
-
Crook, M. (2004). Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabetic Medicine, 21(3), 203-207.
-
(2004)
Diabetic Medicine
, vol.21
, Issue.3
, pp. 203-207
-
-
Crook, M.1
-
4
-
-
70350188297
-
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
-
Maury, E., & Brichard, S. M. (2009). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology, 314(1), 1-16.
-
(2009)
Molecular and Cellular Endocrinology
, vol.314
, Issue.1
, pp. 1-16
-
-
Maury, E.1
Brichard, S.M.2
-
5
-
-
52049098545
-
Visfatin: Structure, function and relation to diabetes mellitus and other dysfunctions
-
Adeghate, E. (2008). Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Current Medicinal Chemistry, 15(18), 1851-1862.
-
(2008)
Current Medicinal Chemistry
, vol.15
, Issue.18
, pp. 1851-1862
-
-
Adeghate, E.1
-
6
-
-
0027958452
-
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor
-
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994). Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology, 14(2), 1431-1437.
-
(1994)
Molecular and Cellular Biology
, vol.14
, Issue.2
, pp. 1431-1437
-
-
Samal, B.1
Sun, Y.2
Stearns, G.3
Xie, C.4
Suggs, S.5
McNiece, I.6
-
7
-
-
23144455313
-
Visfatin: The missing link between intra-abdominal obesity and diabetes?
-
Sethi, J. K., & Vidal-Puig, A. (2005). Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends in Molecular Medicine, 11(8), 344-347.
-
(2005)
Trends in Molecular Medicine
, vol.11
, Issue.8
, pp. 344-347
-
-
Sethi, J.K.1
Vidal-Puig, A.2
-
8
-
-
33846991610
-
Human visfatin expression: Relationship to insulin sensitivity, intramyocellular lipids, and inflammation
-
Varma, V., Yao-Borengasser, A., Rasouli, N., Bodles, A. M., Phanavanh, B., Lee, M. J., et al. (2007). Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. The Journal of Clinical Endocrinology and Metabolism, 92(2), 666-672.
-
(2007)
The Journal of Clinical Endocrinology and Metabolism
, vol.92
, Issue.2
, pp. 666-672
-
-
Varma, V.1
Yao-Borengasser, A.2
Rasouli, N.3
Bodles, A.M.4
Phanavanh, B.5
Lee, M.J.6
-
9
-
-
25844491778
-
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
-
Berndt, J., Kloting, N., Kralisch, S., Kovacs, P., Fasshauer, M., Schon, M. R., et al. (2005). Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 54(10), 2911-2916.
-
(2005)
Diabetes
, vol.54
, Issue.10
, pp. 2911-2916
-
-
Berndt, J.1
Kloting, N.2
Kralisch, S.3
Kovacs, P.4
Fasshauer, M.5
Schon, M.R.6
-
10
-
-
19944433652
-
Visfatin: A protein secreted by visceral fat that mimics the effects of insulin
-
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., et al. (2005). Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 307(5708), 426-430.
-
(2005)
Science
, vol.307
, Issue.5708
, pp. 426-430
-
-
Fukuhara, A.1
Matsuda, M.2
Nishizawa, M.3
Segawa, K.4
Tanaka, M.5
Kishimoto, K.6
-
11
-
-
35549002189
-
Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme
-
Revollo, J. R., Korner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., et al. (2007). Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metabolism, 6(5), 363-375.
-
(2007)
Cell Metabolism
, vol.6
, Issue.5
, pp. 363-375
-
-
Revollo, J.R.1
Korner, A.2
Mills, K.F.3
Satoh, A.4
Wang, T.5
Garten, A.6
-
12
-
-
35848949278
-
Retraction
-
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., et al. (2007). Retraction. Science, 318(5850), 565.
-
(2007)
Science
, vol.318
, Issue.5850
, pp. 565
-
-
Fukuhara, A.1
Matsuda, M.2
Nishizawa, M.3
Segawa, K.4
Tanaka, M.5
Kishimoto, K.6
-
13
-
-
67649674970
-
Overexpression of visfatin/PBEF/Nampt alters wholebody insulin sensitivity and lipid profile in rats
-
Sun, Q., Li, L., Li, R., Yang, M., Liu, H., Nowicki, M. J., et al. (2009). Overexpression of visfatin/PBEF/Nampt alters wholebody insulin sensitivity and lipid profile in rats. Annals of Medicine, 41(4), 311-320.
-
(2009)
Annals of Medicine
, vol.41
, Issue.4
, pp. 311-320
-
-
Sun, Q.1
Li, L.2
Li, R.3
Yang, M.4
Liu, H.5
Nowicki, M.J.6
-
14
-
-
62649156291
-
Nampt: Linking NAD biology, metabolism and cancer
-
Garten, A., Petzold, S., Korner, A., Imai, S., & Kiess, W. (2009). Nampt: linking NAD biology, metabolism and cancer. Trends in Endocrinology and Metabolism, 20(3), 130-138.
-
(2009)
Trends in Endocrinology and Metabolism
, vol.20
, Issue.3
, pp. 130-138
-
-
Garten, A.1
Petzold, S.2
Korner, A.3
Imai, S.4
Kiess, W.5
-
16
-
-
25144459980
-
The metabolic syndrome - A new worldwide definition
-
Alberti, K. G., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome - a new worldwide definition. Lancet, 366(9491), 1059-1062.
-
(2005)
Lancet
, vol.366
, Issue.9491
, pp. 1059-1062
-
-
Alberti, K.G.1
Zimmet, P.2
Shaw, J.3
-
17
-
-
77953049724
-
Appropriate waist circumference cut-off points among Iranian adults: The first report of the Iranian National Committee of Obesity
-
Azizi, F., Khalili, D., Aghajani, H., Esteghamati, A., Hosseinpanah, F., Delavari, A., et al. (2010). Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Archives of Iranian Medicine, 13(3), 243-244.
-
(2010)
Archives of Iranian Medicine
, vol.13
, Issue.3
, pp. 243-244
-
-
Azizi, F.1
Khalili, D.2
Aghajani, H.3
Esteghamati, A.4
Hosseinpanah, F.5
Delavari, A.6
-
18
-
-
44449133335
-
Adolphe Quetelet (1796-1874) - The average man and indices of obesity
-
Eknoyan, G. (2007). Adolphe Quetelet (1796-1874)-the average man and indices of obesity. Nephrology, Dialysis, Transplantation, 23(1), 47-51.
-
(2007)
Nephrology, Dialysis, Transplantation
, vol.23
, Issue.1
, pp. 47-51
-
-
Eknoyan, G.1
-
19
-
-
34447560040
-
Visceral and subcutaneous adiposity: Are both potential therapeutic targets for tackling the metabolic syndrome?
-
Rodriguez, A., Catalan, V., Gomez-Ambrosi, J., & Fruhbeck, G. (2007). Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Current Pharmaceutical Design, 13(21), 2169-2175.
-
(2007)
Current Pharmaceutical Design
, vol.13
, Issue.21
, pp. 2169-2175
-
-
Rodriguez, A.1
Catalan, V.2
Gomez-Ambrosi, J.3
Fruhbeck, G.4
-
20
-
-
72749108455
-
Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
-
Kolsgaard,M. L.,Wangensteen, T., Brunborg, C., Joner, G., Holven, K. B., Halvorsen, B., et al. (2009). Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome. Scandinavian Journal of Clinical and Laboratory Investigation, 69 (8), 858-864.
-
(2009)
Scandinavian Journal of Clinical and Laboratory Investigation
, vol.69
, Issue.8
, pp. 858-864
-
-
Kolsgaard, M.L.1
Wangensteen, T.2
Brunborg, C.3
Joner, G.4
Holven, K.B.5
Halvorsen, B.6
-
21
-
-
34447336403
-
Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome
-
Kowalska, I., Straczkowski, M., Nikolajuk, A., Adamska, A., Karczewska-Kupczewska, M., Otziomek, E., et al. (2007). Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Human Reproduction, 22(7), 1824-1829.
-
(2007)
Human Reproduction
, vol.22
, Issue.7
, pp. 1824-1829
-
-
Kowalska, I.1
Straczkowski, M.2
Nikolajuk, A.3
Adamska, A.4
Karczewska-Kupczewska, M.5
Otziomek, E.6
-
22
-
-
79958034079
-
Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome
-
Cekmez F, Cekmez Y, Pirgon O, Emre Canpolat F, Aydinoz S, Metin Ipcioglu O, et al. (2011). Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome. European Cytokine Network, 22.
-
(2011)
European Cytokine Network
, pp. 22
-
-
Cekmez, F.1
Cekmez, Y.2
Pirgon, O.3
Emre Canpolat, F.4
Aydinoz, S.5
Metin Ipcioglu, O.6
-
23
-
-
77953514528
-
An evaluation of visfatin levels in obese subjects
-
Kaminska, A., Kopczynska, E., Bronisz, A., Zmudzinska, M., Bielinski, M., Borkowska, A., et al. (2010). An evaluation of visfatin levels in obese subjects. Endokrynologia Polska, 61(2), 169-173.
-
(2010)
Endokrynologia Polska
, vol.61
, Issue.2
, pp. 169-173
-
-
Kaminska, A.1
Kopczynska, E.2
Bronisz, A.3
Zmudzinska, M.4
Bielinski, M.5
Borkowska, A.6
-
24
-
-
80054953173
-
Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity
-
Nov 29
-
Esteghamati A, Alamdari A, Zandieh A, Elahi S, Khalilzadeh O, Nakhjavani M, et al. (2010). Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity. Diabetes Research and Clinical Practice, 29. Nov 29.
-
(2010)
Diabetes Research and Clinical Practice
, pp. 29
-
-
Esteghamati, A.1
Alamdari, A.2
Zandieh, A.3
Elahi, S.4
Khalilzadeh, O.5
Nakhjavani, M.6
-
25
-
-
33749433515
-
The adipokine visfatin is markedly elevated in obese children
-
Haider, D. G., Holzer, G., Schaller, G., Weghuber, D., Widhalm, K., Wagner, O., et al. (2006). The adipokine visfatin is markedly elevated in obese children. Journal of Pediatric Gastroenterology and Nutrition, 43(4), 548-549.
-
(2006)
Journal of Pediatric Gastroenterology and Nutrition
, vol.43
, Issue.4
, pp. 548-549
-
-
Haider, D.G.1
Holzer, G.2
Schaller, G.3
Weghuber, D.4
Widhalm, K.5
Wagner, O.6
-
26
-
-
33750867485
-
Serum visfatin increases with progressive beta-cell deterioration
-
Lopez-Bermejo, A., Chico-Julia, B., Fernandez-Balsells, M., Recasens, M., Esteve, E., Casamitjana, R., et al. (2006). Serum visfatin increases with progressive beta-cell deterioration. Diabetes, 55(10), 2871-2875.
-
(2006)
Diabetes
, vol.55
, Issue.10
, pp. 2871-2875
-
-
Lopez-Bermejo, A.1
Chico-Julia, B.2
Fernandez-Balsells, M.3
Recasens, M.4
Esteve, E.5
Casamitjana, R.6
-
27
-
-
34548389205
-
Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans
-
Epub 2007 Jul 3
-
Meier, J. J., Holst, J. J., Schmidt, W. E., & Nauck, M. A. (2007). Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans. American Journal of Physiology. Endocrinology and Metabolism, 293(3), E849-E856. Epub 2007 Jul 3.
-
(2007)
American Journal of Physiology. Endocrinology and Metabolism
, vol.293
, Issue.3
-
-
Meier, J.J.1
Holst, J.J.2
Schmidt, W.E.3
Nauck, M.A.4
-
28
-
-
33644747113
-
The metabolic syndrome: A global public health problem and a new definition
-
Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G., & Shaw, J. (2005). The metabolic syndrome: a global public health problem and a new definition. Journal of Atherosclerosis and Thrombosis, 12(6), 295-300.
-
(2005)
Journal of Atherosclerosis and Thrombosis
, vol.12
, Issue.6
, pp. 295-300
-
-
Zimmet, P.1
Magliano, D.2
Matsuzawa, Y.3
Alberti, G.4
Shaw, J.5
|